收费全文 | 58560篇 |
免费 | 3811篇 |
国内免费 | 261篇 |
耳鼻咽喉 | 730篇 |
儿科学 | 1355篇 |
妇产科学 | 1453篇 |
基础医学 | 8281篇 |
口腔科学 | 1690篇 |
临床医学 | 6432篇 |
内科学 | 12485篇 |
皮肤病学 | 1011篇 |
神经病学 | 5708篇 |
特种医学 | 2012篇 |
外科学 | 7465篇 |
综合类 | 389篇 |
一般理论 | 47篇 |
预防医学 | 4168篇 |
眼科学 | 1011篇 |
药学 | 4092篇 |
1篇 | |
中国医学 | 76篇 |
肿瘤学 | 4226篇 |
2023年 | 349篇 |
2022年 | 588篇 |
2021年 | 1298篇 |
2020年 | 838篇 |
2019年 | 1125篇 |
2018年 | 1381篇 |
2017年 | 1195篇 |
2016年 | 1396篇 |
2015年 | 1458篇 |
2014年 | 1947篇 |
2013年 | 2852篇 |
2012年 | 4182篇 |
2011年 | 4366篇 |
2010年 | 2608篇 |
2009年 | 2361篇 |
2008年 | 3605篇 |
2007年 | 3968篇 |
2006年 | 3540篇 |
2005年 | 3568篇 |
2004年 | 3307篇 |
2003年 | 3090篇 |
2002年 | 2849篇 |
2001年 | 677篇 |
2000年 | 597篇 |
1999年 | 680篇 |
1998年 | 651篇 |
1997年 | 538篇 |
1996年 | 455篇 |
1995年 | 426篇 |
1994年 | 374篇 |
1993年 | 369篇 |
1992年 | 414篇 |
1991年 | 428篇 |
1990年 | 366篇 |
1989年 | 374篇 |
1988年 | 336篇 |
1987年 | 328篇 |
1986年 | 318篇 |
1985年 | 350篇 |
1984年 | 292篇 |
1983年 | 265篇 |
1982年 | 260篇 |
1981年 | 206篇 |
1980年 | 191篇 |
1979年 | 223篇 |
1978年 | 197篇 |
1977年 | 194篇 |
1976年 | 152篇 |
1975年 | 157篇 |
1974年 | 132篇 |
Areas covered: We discuss the current understanding of the HH pathway as it relates to normal hematopoiesis, the pathology of acute myeloid leukemia (AML), the rationale for and data from combination therapies including HH pathway inhibitors, and ultimately the prospects that might offer promise in targeting this pathway in AML.
Expert opinion: Efforts to target the HH pathway have been focused on impeding this disposition and restoring chemosensitivity to conventional myeloid neoplasm therapies. The year 2018 saw the first approval of a HH pathway inhibitor (glasdegib) for AML, though for an older population and in combination with an uncommonly-used therapy. Several other clinical trials with agents targeting modulators of HH signaling in AML and MDS are underway. Further study and understanding of the interplay between the numerous aspects of HH signaling and how it relates to the augmented survival of AML will provide a more reliable substrate for therapeutic strategies in patients with this poor-risk disease. 相似文献
Forensic age estimation generally involves considerable amounts of uncertainty. Forensic age indicators such as teeth or skeleton images predict age only approximately, and this is likely to remain true even for future forensic age indicators. Thus, forensic age assessment should aim to make the best possible decisions under uncertainty. In this paper, we apply mathematical theory to make statistically optimal decisions to age assessment. Such an application is fairly straightforward assuming there is a standardized procedure for obtaining age indicator information from individuals, assuming we have data from the application of this procedure to a group of persons with known ages, and assuming the starting point for each individual is a probability distribution describing prior knowledge about the persons age. The main problem is then to obtain such a prior. Our analysis indicates that individual priors rather than a common prior for all persons may be necessary. We suggest that caseworkers, based on individual case information, may select a prior from a menu of priors. We show how information may then be collected over time to gradually increase the robustness of the decision procedure. We also show how replacing individual prior distributions for age with individual prior odds for being above an age limit cannot be recommended as a general method. Our theoretical framework is applied to data where the maturity of the distal femur and the third molar is observed using MRI. As part of this analysis we observe a weak positive conditional correlation between maturity of the two body parts.
相似文献